Elanco Animal Health [ELAN] vs United Therapeutics [UTHR] Detailed Stock Comparison

Elanco Animal Health Inc.

NYSE
Loading...

United Therapeutics Corporation

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Elanco Animal Health Inc. wins in 5 metrics, United Therapeutics Corporation wins in 15 metrics, with 0 ties. United Therapeutics Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Elanco Animal Health Inc. United Therapeutics Corporation Better
P/E Ratio (TTM) 377.14 20.60 United Therapeutics Corporation
Price-to-Book Ratio 1.72 3.53 Elanco Animal Health Inc.
Debt-to-Equity Ratio 67.89 0.53 United Therapeutics Corporation
PEG Ratio 0.14 0.83 Elanco Animal Health Inc.
EV/EBITDA 16.68 13.90 United Therapeutics Corporation
Profit Margin (TTM) -4.92% 41.94% United Therapeutics Corporation
Operating Margin (TTM) 2.27% 45.23% United Therapeutics Corporation
EBITDA Margin (TTM) 2.27% 45.23% United Therapeutics Corporation
Return on Equity -3.67% 19.72% United Therapeutics Corporation
Return on Assets (TTM) 1.25% 12.44% United Therapeutics Corporation
Free Cash Flow (TTM) $284.00M $1.04B United Therapeutics Corporation
1-Year Return 75.02% 92.68% United Therapeutics Corporation
Price-to-Sales Ratio (TTM) 2.39 7.91 Elanco Animal Health Inc.
Enterprise Value $15.14B $22.28B United Therapeutics Corporation
EV/Revenue Ratio 3.21 7.00 Elanco Animal Health Inc.
Gross Profit Margin (TTM) 51.49% 86.91% United Therapeutics Corporation
Revenue per Share (TTM) $10 $72 United Therapeutics Corporation
Earnings per Share (Diluted) $-0.47 $27.88 United Therapeutics Corporation
Beta (Stock Volatility) 1.88 0.75 United Therapeutics Corporation
Short % of Float 8.13% 8.58% Elanco Animal Health Inc.

Elanco Animal Health Inc. vs United Therapeutics Corporation Stock Performance Analysis

Loading Price Chart...

ELAN
UTHR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Elanco Animal Health Inc.0.50%2.58%22.31%3.80%11.94%7.86%
United Therapeutics Corporation0.66%0.90%-3.34%2.86%9.85%10.64%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Elanco Animal Health Inc.75.02%133.08%-30.33%-29.12%-29.12%-29.12%
United Therapeutics Corporation92.68%137.11%205.88%434.68%903.79%2,026.01%

Performance & Financial Health Analysis: Elanco Animal Health Inc. vs United Therapeutics Corporation

MetricELANUTHR
Market Information
Market Cap i$11.18B$25.11B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i4,096,539464,464
90 Day Avg. Volume i5,352,890635,891
Last Close$24.29$549.57
52 Week Range$13.16 - $27.72$272.12 - $609.35
% from 52W High-12.37%-9.81%
All-Time High$37.61 (Sep 24, 2018)$609.35 (May 06, 2026)
% from All-Time High-35.42%-9.81%
Growth Metrics
Quarterly Revenue Growth0.12%0.07%
Quarterly Earnings Growth0.12%0.21%
Financial Health
Profit Margin (TTM) i-0.05%0.42%
Operating Margin (TTM) i0.02%0.45%
Return on Equity (TTM) i-0.04%0.20%
Debt to Equity (MRQ) i67.890.53
Cash & Liquidity
Book Value per Share (MRQ)$13.17$162.60
Cash per Share (MRQ)$1.10$66.63
Operating Cash Flow (TTM) i$560.00M$1.56B
Levered Free Cash Flow (TTM) i$559.75M$583.20M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Elanco Animal Health Inc. vs United Therapeutics Corporation

MetricELAN (Apr 23, 2026)UTHR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i377.1420.60
Forward P/E i19.3516.87
PEG Ratio i0.140.83
Price to Sales (TTM) i2.397.91
Price to Book (MRQ) i1.723.53
Market Capitalization
Market Capitalization i$11.18B$25.11B
Enterprise Value i$15.14B$22.28B
Enterprise Value Metrics
Enterprise to Revenue i3.217.00
Enterprise to EBITDA i16.6813.90
Risk & Other Metrics
Beta i1.880.75
Book Value per Share (MRQ) i$13.17$162.60

Financial Statements Comparison: Elanco Animal Health Inc. vs United Therapeutics Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricELAN (2025)UTHR (2025)
Revenue/Sales i4.72B3.18B
Cost of Goods Sold i2.12B384.40M
COGS % of Revenue i45.0%12.1%
Gross Profit i2.59B2.80B
Gross Margin i55.0%87.9%
Research & Development i368.00M550.00M
Operating Income (EBIT) i252.00M1.52B
Operating Margin i5.3%47.7%
EBITDA i913.00M1.84B
EBITDA Margin i19.4%57.9%
Pre-Tax Income i-224.00M1.71B
Pre-Tax Income % of Revenue i-4.8%53.9%
Income Tax i8.00M379.20M
Income Tax % of Revenue i0.2%11.9%
Net Income (Profit) i-232.00M1.33B
Profit Margin i-4.9%41.9%

Balance Sheet & Liquidity Metrics

MetricELAN (2025)UTHR (2025)
Cash & Equivalents i545.00M1.56B
Total Current Assets i3.46B3.70B
Total Current Assets % of Revenue i73.3%116.3%
Total Current Liabilities i1.60B560.60M
Total Current Liabilities % of Revenue i33.9%17.6%
Long-Term Debt i3.94BN/A
Long-Term Debt % of Revenue i83.6%0.0%
Total Shareholders Equity i6.55B7.10B
Retained Earnings i-2.18B8.56B
Retained Earnings % of Revenue i-46.3%268.9%
Property, Plant & Equipment i1.33B0

Cash Flow Statement Comparison

MetricELAN (2025)UTHR (2025)
Operating Cash Flow i489.00M1.44B
Operating Cash Flow % of Revenue i10.4%45.3%
Capital Expenditures i-276.00M-520.50M
Free Cash Flow i284.00M1.04B
FCF Margin i6.0%32.5%
Debt Repayment i-2.92B-500.00M
Common Stock Repurchase iN/A-1.02B

Short Interest & Institutional Ownership Analysis

MetricELANUTHR
Shares Short i25.54M2.84M
Short Ratio i4.534.40
Short % of Float i8.13%8.58%
Shares Outstanding i496.98M43.64M
Float Shares i492.68M40.32M
% Held by Insiders i1.19%1.94%
% Held by Institutions i109.45%97.78%
% Held by Public i-10.64%0.28%

Dividend Analysis & Yield Comparison: Elanco Animal Health Inc. vs United Therapeutics Corporation

MetricELANUTHR
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A